Literature DB >> 23544948

Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.

Nadia Naderi1, David T Yang.   

Abstract

Lymphoplasmacytic lymphoma (LPL) is a low-grade, B-cell neoplasm composed of small lymphocytes, plasmacytoid lymphocytes, and plasma cells that typically involve the bone marrow, and it is associated with an immunoglobulin M (IgM) gammopathy. The definition of Waldenström macroglobulinemia (WM) and its relationship to LPL has been confusing in the past. In addition, the diagnosis of LPL itself can be challenging because LPL lacks disease-specific morphologic, immunophenotypic, and genetic features to differentiate it from other mature B-cell neoplasms. Accurate diagnosis of LPL/WM rests on recognition of the differential diagnostic features between LPL and other diagnostic possibilities and the use of the recently refined definition of WM and its relationship with LPL: The presence of an IgM monoclonal gammopathy of any level in the setting of bone marrow involvement by LPL. This review summarizes the clinical, laboratory, and histologic features of LPL/WM, with particular emphasis on unique aspects of LPL/WM that may aid in accurate diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 23544948     DOI: 10.5858/arpa.2012-0034-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  External-Beam Radiotherapy Alone Management of Primary CNS Lymphoplasmacytic Lymphoma: A Vietnamese Case Report and Literature Review.

Authors:  Dang Nguyen Van; Nghia Duong Van; Quang Le Van; Tung Ngo Thanh; To Ta Van
Journal:  J Blood Med       Date:  2021-08-21

2.  Acute kidney injury due to direct infiltration by lymphoplasmacytic lymphoma secreting IgG paraproteins: A case report.

Authors:  Seongmin Kim; Wooram Bae; Jungyoon Choi; Tae Won Lee; Dae Hyun Song; Eunjin Bae; Ha Nee Jang; Se-Ho Chang; Dong Jun Park
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

3.  Russell Body Esophagitis: A Possible Indication to Screen for Hematologic Malignancy.

Authors:  Glenn E Garcia; Muhammed R Hiba; Joseph Staffetti
Journal:  Cureus       Date:  2022-06-24

4.  A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation.

Authors:  Yosuke Matsumoto; Tetsuya Masuda; Ayako Nishimura; Hideki Horie; Kenichi Harada; Mihoko Yoshida; Kazuho Shimura; Hiroto Kaneko; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2019-09-21       Impact factor: 2.490

5.  A novel mutation of thyroid hormone receptor β in exon 10 in a case of thyroid hormone-resistant non-Hodgkin's lymphoma of the thyroid.

Authors:  Ke Chen; Yanhong Xie; Liling Zhao; Shaoli Zhao; Honghui He; Zhaohui Mo
Journal:  Oncol Lett       Date:  2014-11-20       Impact factor: 2.967

Review 6.  An uncommon case of lymphoplasmacytic lymphoma in cerebellopontine angle region: Case report with a literature review.

Authors:  Chengrui Yan; Xiangyi Kong; Lanshu Yang; Wenbin Ma
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

7.  Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report.

Authors:  Hany S Attallah; Mufaddal Moonim; Paul Fields; David Wrench; Jessica Brady; N George Mikhaeel
Journal:  Am J Case Rep       Date:  2020-07-20

8.  Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets.

Authors:  Andrea Cona; Daniele Tesoro; Margherita Chiamenti; Esther Merlini; Daris Ferrari; Antonio Marti; Carla Codecà; Giuseppe Ancona; Camilla Tincati; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

9.  Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10-.

Authors:  Guido D'Angelo; Anna Maria Hotz; Marta Monti
Journal:  Blood Res       Date:  2013-12-24

Review 10.  Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.

Authors:  Jonas Paludo; Stephen M Ansell
Journal:  F1000Res       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.